The global vitamin K2 market is estimated to be USD 140 million in 2024 and poised to achieve a 13.7% CAGR, reaching USD 265 million by 2029. As people become more informed about the role of vitamins in preventing chronic diseases, there is a heightened demand for Vitamin K2 due to its critical function in bone and cardiovascular health. Awareness campaigns and educational programs significantly contribute to this trend, emphasizing the benefits of Vitamin K2 in maintaining calcium balance and reducing the risk of osteoporosis and arterial calcification.
The global demographic shift towards an aging population is another significant factor propelling the Vitamin K2 market. Older adults are more susceptible to bone density loss and cardiovascular diseases, conditions that Vitamin K2 helps mitigate. As life expectancy increases, so does the need for nutritional supplements that support healthy aging. Consequently, the market for Vitamin K2 is experiencing substantial growth as it becomes an integral component of the dietary regimen for the elderly.
Vitamin K2 Market Drivers: Growth in health consciousness among consumers and increasing health expenditure
The Vitamin K2 market is witnessing significant growth, driven by the rising health awareness among consumers and increasing global health expenditures. As more individuals prioritize preventive healthcare, there is a growing demand for dietary supplements that support long-term well-being. This trend spans across various demographics, from younger consumers focused on maintaining their health to older populations seeking to address age-related health concerns. The growing emphasis on holistic wellness is encouraging consumers to invest in products that provide targeted health benefits, such as improved bone density and cardiovascular health, both of which are linked to Vitamin K2. Moreover, rising disposable incomes and increased health spending are allowing consumers to invest in premium health products, further fueling the demand for Vitamin K2 supplements.
Pharmaceuticals Rise as the Second Leading Application Segment in the Vitamin K2 Market
The pharmaceutical sector is gaining prominence due to its extensive therapeutic benefits and increasing incorporation into medical treatments. Vitamin K2’s significance in pharmaceuticals is driven by its role in preventing and managing conditions such as osteoporosis, cardiovascular diseases, and certain types of cancer. As research continues to highlight the numerous health benefits of vitamin K2, its integration into pharmaceutical products is becoming more widespread.
Furthermore, the potential anticancer properties of vitamin K2 are drawing significant attention within the pharmaceutical industry. Studies suggest that vitamin K2 can induce apoptosis (programmed cell death) in cancer cells and inhibit their proliferation. According to an NCBI study, vitamin K2 has been found to induce differentiation and apoptosis across various human cancer cell lines. However, it’s important to note that vitamin K2-induced apoptosis tends to occur more slowly compared to conventional anticancer agents. The inclusion of vitamin K2 in pharmaceutical formulations could therefore open new therapeutic avenues, offering patients innovative treatment options.
Asia Pacific Poised to Lead the Vitamin K2 Market Share
The Asia Pacific region is rapidly emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. A key driver of this growth is the region’s rapidly aging population. Countries like Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related conditions such as osteoporosis and cardiovascular issues. This demographic shift is creating strong demand for nutritional supplements that support bone health and prevent arterial calcification, positioning Vitamin K2 as a critical nutrient.
Additionally, the robust expansion of the e-commerce sector in the Asia Pacific region has facilitated easier access to a wide range of Vitamin K2 products, contributing to market growth. Online platforms such as Amazon, Alibaba, and other regional e-commerce giants have increased the visibility and availability of Vitamin K2 supplements. These platforms have enabled broader distribution networks, reached even remote areas and providing consumers with convenient access to a variety of products.
Consumers now enjoy the convenience of purchasing Vitamin K2 supplements from their homes or workplaces, leading to a seamless shopping experience. The extensive range of choices and competitive pricing available on e-commerce platforms has become increasingly appealing. Furthermore, online platforms offer comprehensive product information, customer reviews, and expert guidance, empowering consumers to make well-informed decisions about their health and wellness needs.
Leading Vitamin K2 Companies:
The key players in this market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea)
Kappa Bioscience AS (Balchem Corp.) (US)
Since 2022, Kappa Bioscience has been part of Balchem Corporation, a US-based global leader in specialty ingredients focused on nutrition and health. Balchem, a public company, operates in human and animal nutrition and health. With a strong presence in over 70 countries and major subsidiaries like Albion International and SensoryEffects Inc., Balchem serves the food, beverage, pharmaceutical, and dietary supplement industries. Kappa Bioscience, a leading vitamin K2 producer from Norway, is part of Balchem’s human nutrition and health segment. It has a geographical presence in over 70 countries across six continents.
In March 2022, Kappa Bioscience established a “Blue Ribbon” Scientific and Medical Advisory Board composed of prominent scientists from various fields. The advisory board aims to deepen and expand the scientific understanding of Menaquinone 7 (MK-7) Vitamin K2 and its associated health benefits.
J-OIL MILLS INC. (Japan)
J-OIL MILLS INC., headquartered in Japan, specializes in manufacturing and selling edible oils and fats, operating through its oils & fats and specialty food products segments. It also offers services like real estate leasing. The company addresses health, food safety, animal health, and environmental sustainability needs. Known for its expertise in Ajinomoto production, it has subsidiaries in Malaysia and Thailand. J-OIL Mills produces Vitamin K2, marketed in North America by PLT Health Solutions under the “Menatto” brand. Developed in 1997, Menatto has been researched in ten human clinical trials. PLT Health Solutions, with over 70 years of experience, has been in the Vitamin K2 business for nearly twenty years.
In March 2023, PLT Health Solutions, Inc. announced a partnership with J-OIL MLLS INC. to market the menatto brand of Vitamin K2 (MK-7) in North America. This premium-quality ingredient, developed by J-Oil Mills in 1997, utilizes fermentation technology with Bacillus subtilis isolated from the traditional Japanese food natto. Since its inception, menatto has been the subject of ten human clinical trials, including research on bioavailability, bone health, and cardiovascular health.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=80962397
About MarketsandMarkets™
MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/vitamin-k2-market-80962397.html